The Swiss drug maker will pay $275 million upfront for privately held IQuum of Massachusetts and up to an additional $175 million based on the company reaching certain product milestones.
via NYT > Business Day http://ift.tt/1hkErVA
via WordPress http://ift.tt/1e7k6Tw
via All Business Is Good Business http://ift.tt/QWsYRy
via May 21st 2011 wrong http://ift.tt/1mTIDek
No comments:
Post a Comment